CTT Pharmaceutical Holdings, Inc. (CTTH)

Market Cap	4.42M
Revenue (ttm)	n/a
Net Income (ttm)	-1.67M
Shares Out	57.13M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	43,451
Open	0.0650
Previous Close	0.0774
Day's Range	0.0650 - 0.0650
52-Week Range	0.0141 - 0.1518
Beta	0.73
RSI	60.24
Earnings Date	n/a

About CTTH

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film for...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Ryan Khouri
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: CTTH